Chevy Chase Trust
MRNA icon

Chevy Chase Trust’s Moderna MRNA Stock Holding History

Chevy Chase Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Sell
170,580
-738
-0.4% -$38.2K 0.03% 380
2026
Q1 		$8.7M Sell
171,318
-4,994
-3% -$233K 0.03% 431
2025
Q4 		$5.2M Sell
176,312
-413
-0.2% -$11.2K 0.01% 511
2025
Q3 		$4.56M Sell
176,725
-3,043
-2% -$84.9K 0.01% 515
2025
Q2 		$4.96M Buy
179,768
+2,161
+1% +$56.9K 0.01% 510
2025
Q1 		$5.04M Sell
177,607
-96
-0.1% -$3.41K 0.02% 509
2024
Q4 		$7.39M Sell
177,703
-3,913
-2% -$187K 0.02% 464
2024
Q3 		$12.1M Sell
181,616
-1,028
-0.6% -$94.4K 0.04% 368
2024
Q2 		$21.7M Sell
182,644
-1,647
-0.9% -$208K 0.07% 235
2024
Q1 		$19.6M Sell
184,291
-1,358
-0.7% -$137K 0.06% 263
2023
Q4 		$18.5M Sell
185,649
-823
-0.4% -$69.2K 0.07% 270
2023
Q3 		$19.3M Sell
186,472
-2,478
-1% -$276K 0.08% 239
2023
Q2 		$23M Sell
188,950
-3,399
-2% -$453K 0.09% 213
2023
Q1 		$29.5M Buy
192,349
+1,958
+1% +$323K 0.12% 167
2022
Q4 		$34.2M Sell
190,391
-15,138
-7% -$2.48M 0.15% 142
2022
Q3 		$24.3M Sell
205,529
-3,453
-2% -$524K 0.1% 185
2022
Q2 		$29.9M Sell
208,982
-3,972
-2% -$568K 0.12% 166
2022
Q1 		$36.7M Buy
212,954
+607
+0.3% +$102K 0.13% 158
2021
Q4 		$53.9M Sell
212,347
-4,159
-2% -$1.22M 0.17% 121
2021
Q3 		$83.3M Buy
+216,506
New +$79.8M 0.29% 83

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Chevy Chase Trust's MRNA Position: Q2 2026 in Review

Chevy Chase Trust reduced its Moderna (MRNA) stake by 0.43% in Q2 2026, selling an estimated $38.2K and leaving 170,580 shares worth $11.9M. The position accounts for 0.03% of the portfolio, ranked #380.

Chevy Chase Trust first reported a position in MRNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $83.3M in Q3 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Chevy Chase Trust held 170,580 shares of Moderna worth $11.9M as of Q2 2026.
  • Chevy Chase Trust sold 738 Moderna shares in Q2 2026, an estimated $38.2K.
  • Moderna made up 0.03% of Chevy Chase Trust's portfolio in Q2 2026, its #380 holding.
  • Chevy Chase Trust first reported a position in Moderna in Q3 2021 and has held it in 20 quarters since.
  • Chevy Chase Trust's Moderna position peaked at $83.3M in Q3 2021.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.